GGrantIndex
Sort

40,608 grants matching prostate cancer

TARGETING FLIP FOR PROSTATE CANCER PREVENTION

$308,138
Addanki P Kumar · University Of Texas Hlth Science Center · R01 · FY2010 · CA

Enhancing Bioavailability of Resveratrol

$308,138
Nihal Ahmad · University Of Wisconsin-Madison · R21 · FY2010 · CA

Targeting AR and Akt for the Treatment of Prostate Cancer

$308,138
Chendil Damodaran · University Of Kentucky · R01 · FY2010 · CA

Oxidative stress in prostate cancer: Efficacy of antioxidants in Nkx3.1; Pten mod

$308,138
Rita Ghosh · University Of Texas Hlth Science Center · R01 · FY2010 · CA

Project 4: Clinical Development of Therapeutic Strategies Targeting Damage Repair

$308,123
Peter S Nelson · Fred Hutchinson Cancer Center · P50 · FY2023 · CA

Post-translational regulation of CYP17 activity

$308,066
Denis A Magoffin · Cedars-Sinai Medical Center · R01 · FY2008 · HD

Novel roles of microRNA in androgen receptor signaling

$308,025
Allen C Gao · University Of California At Davis · R01 · FY2017 · CA

UNRAVELING THE DYNAMIC PROTEIN EXPRESSION LEVELS OF ANDROGEN RECEPTOR VARIANTS IN PROSTATE CANCER

$308,000
University Of Minnesota Foundation · · FY2020 · Defense Health Agency

The RAP80-BRCC36 Deubiquitinating Complex in DNA Repair

$307,982
Roger A Greenberg · University Of Pennsylvania · R01 · FY2019 · CA

Enhancing Native American Participation in RT Trials

$307,973
Rapid City Regional Hospital · U56 · FY2004 · CA

Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers

$307,954
Joe W. Gray · Oregon Health & Science University · U2C · FY2022 · CA

Hybrid nanotechnology to target metastatic advanced prostate cancer

$307,951
Ho-Lun Wong · Temple Univ Of The Commonwealth · R01 · FY2014 · CA

MRI-Guided Radiotherapy and Biomarkers for Prostate Cancer

$307,951
Alan Pollack · University Of Miami School Of Medicine · R21 · FY2011 · CA

Modulation of regulatory cell function in cancer immunotherapy

$307,951
Piotr J Kraj · Old Dominion University · R01 · FY2014 · CA

Participation in Cytochrome b5 in Anesthetic Metabolism

$307,948
Lucy A Waskell · University Of Michigan At Ann Arbor · R01 · FY2009 · GM

Primary Prevention Versus Screening for Prostate Cancer

$307,940
Fred Hutchinson Cancer Research Center · R01 · FY2004 · CA

Primary Prevention Versus Screening for Prostate Cancer

$307,940
Fred Hutchinson Cancer Research Center · R01 · FY2005 · CA

ADAM: Androgen Deprivation vs. Antiandrogen Monotherapy

$307,940
Massachusetts General Hospital · R21 · FY2004 · CA

ADAM: Androgen Deprivation vs. Antiandrogen Monotherapy

$307,940
Massachusetts General Hospital · R21 · FY2003 · CA

Modulation of host intrinsic immunity to reduce prostate cancer disparity

$307,918
Dev Karan · Medical College Of Wisconsin · R01 · FY2020 · CA

Modulation of host intrinsic immunity to reduce prostate cancer disparity

$307,918
Dev Karan · Medical College Of Wisconsin · R01 · FY2021 · CA

Statewide Cancer Data

$307,904
Andrew Olshan · Univ Of North Carolina Chapel Hill · P30 · FY2022 · CA

Statewide Cancer Data

$307,904
Andrew Olshan · Univ Of North Carolina Chapel Hill · P30 · FY2023 · CA

Statewide Cancer Data

$307,904
Andrew Olshan · Univ Of North Carolina Chapel Hill · P30 · FY2021 · CA

Nuclear Targets of Akt Oncoproteins

$307,895
Scripps Research Institute · R01 · FY2002 · CA